Recombinant Human Prolactin

DRUG4 trials

Sponsors

Massachusetts General Hospital

Conditions

HealthyLactation

Phase 2

Recombinant Human Prolactin for Lactation Induction

CompletedNCT00181610

Massachusetts General HospitalLactation

Start: 2004-09-30End: 2010-09-30Updated: 2018-01-03

Recombinant Human Prolactin for Lactation Induction

CompletedNCT00181610

Massachusetts General HospitalLactation

Start: 2004-09-30End: 2010-09-30Updated: 2018-01-03

Recombinant Human Prolactin for Lactation Induction

CompletedNCT00181623

Massachusetts General HospitalLactation

Start: 2005-01-31End: 2011-05-31Updated: 2017-12-11

Recombinant Human Prolactin for Lactation Induction

WithdrawnNCT00181649

Massachusetts General HospitalLactation

Start: 2006-09-30End: 2011-05-31Updated: 2013-05-09

The Safety and Efficacy of Recombinant Human Prolactin

CompletedNCT00438490

Massachusetts General HospitalHealthy

Start: 2002-04-30End: 2011-03-31Updated: 2018-01-03

Related Papers

Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent.

2007-07-244 citations